Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-20

Clinical Trial Update: Liraglutide in Adolescents With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating liraglutide in adolescents with Type 1 diabetes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: University at Buffalo | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2025-04-20